1. Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study. (15th November 2017) Authors: Bissonnette, R.; Haydey, R.; Rosoph, L.A.; Lynde, C.W.; Bukhalo, M.; Fowler, J.F.; Delorme, I.; Gagné‐Henley, A.; Gooderham, M.; Poulin, Y.; Barber, K.; Jenkin, P.; Landells, I.; Pariser, D.M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 3(2018) Page Start: 403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Hand eczema in children referred for patch testing: North American Contact Dermatitis Group Data, 2000–2016. (1st July 2021) Authors: Silverberg, J.I.; Warshaw, E.M.; Maibach, H.I.; DeKoven, J.G.; Taylor, J.S.; Atwater, A.R.; Sasseville, D.; Zug, K.A.; Reeder, M.J.; Fowler, J.F.; Pratt, M.D.; Fransway, A.F.; Zirwas, M.J.; Belsito, D.V.; Marks, J.G.; DeLeo, V.A. Journal: British journal of dermatology Issue: Volume 185:Number 1(2021) Page Start: 185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Hand eczema in children referred for patch testing: North American Contact Dermatitis Group Data, 2000–2016. (31st March 2021) Authors: Silverberg, J.I.; Warshaw, E.M.; Maibach, H.I.; DeKoven, J.G.; Taylor, J.S.; Atwater, A.R.; Sasseville, D.; Zug, K.A.; Reeder, M.J.; Fowler, J.F.; Pratt, M.D.; Fransway, A.F.; Zirwas, M.J.; Belsito, D.V.; Marks, J.G.; DeLeo, V.A. Journal: British journal of dermatology Issue: Volume 185:Number 1(2021) Page Start: 185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase III randomized study of the proposed adalimumab biosimilar GP2017 in psoriasis: impact of multiple switches. (15th July 2018) Authors: Blauvelt, A.; Lacour, J.‐P.; Fowler, J.F.; Weinberg, J.M.; Gospodinov, D.; Schuck, E.; Jauch‐Lembach, J.; Balfour, A.; Leonardi, C.L. Journal: British journal of dermatology Issue: Volume 179:Number 3(2018) Page Start: 623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase III randomized study of the proposed adalimumab biosimilar GP2017 in psoriasis: impact of multiple switches. (1st September 2018) Authors: Blauvelt, A.; Lacour, J.‐P.; Fowler, J.F.; Weinberg, J.M.; Gospodinov, D.; Schuck, E.; Jauch‐Lembach, J.; Balfour, A.; Leonardi, C.L. Journal: British journal of dermatology Issue: Volume 179:Number 3(2018) Page Start: 623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗